A detailed history of Cibc World Market Inc. transactions in United Therapeutics Corp stock. As of the latest transaction made, Cibc World Market Inc. holds 15,216 shares of UTHR stock, worth $5.53 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
15,216
Previous 5,058 200.83%
Holding current value
$5.53 Million
Previous $1.61 Million 238.49%
% of portfolio
0.01%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $3.16 Million - $3.69 Million
10,158 Added 200.83%
15,216 $5.45 Million
Q2 2024

Aug 07, 2024

BUY
$228.26 - $319.04 $1.15 Million - $1.61 Million
5,058 New
5,058 $1.61 Million
Q2 2022

Aug 10, 2022

BUY
$174.81 - $241.14 $173,236 - $238,969
991 New
991 $234,000
Q2 2019

Aug 08, 2019

SELL
$76.06 - $120.81 $1.16 Million - $1.84 Million
-15,201 Closed
0 $0
Q1 2019

May 09, 2019

SELL
$107.15 - $126.84 $8,786 - $10,400
-82 Reduced 0.54%
15,201 $1.78 Million
Q4 2018

Feb 13, 2019

SELL
$101.4 - $128.73 $425,981 - $540,794
-4,201 Reduced 21.56%
15,283 $1.66 Million
Q3 2018

Nov 09, 2018

SELL
$113.81 - $129.46 $216,808 - $246,621
-1,905 Reduced 8.91%
19,484 $2.49 Million
Q2 2018

Aug 08, 2018

BUY
$101.14 - $118.31 $1.66 Million - $1.94 Million
16,404 Added 329.07%
21,389 $2.42 Million
Q1 2018

May 18, 2018

BUY
$107.21 - $151.94 $380,488 - $539,235
3,549 Added 247.14%
4,985 $560,000
Q4 2017

Feb 01, 2018

SELL
$118.58 - $151.28 $274,275 - $349,910
-2,313 Reduced 61.7%
1,436 $212,000
Q3 2017

Nov 13, 2017

BUY
$114.6 - $136.81 $429,635 - $512,900
3,749
3,749 $439,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.6B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.